EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 14 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,000 | -33.3% | 9,226 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -25.0% | 9,226 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | +33.3% | 9,226 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 9,226 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 9,226 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 9,226 | +2934.9% | 0.00% | – |
| Q4 2017 | $0 | – | 304 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 304 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 304 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 106,561 | $304,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 243,790 | $695,000 | 0.03% |
| Vantage Investment Advisors, LLC | 6,500 | $19,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 9,693 | $28,000 | 0.00% |
| UBS Group AG | 3,964 | $11,000 | 0.00% |
| MORGAN STANLEY | 1,199 | $3,000 | 0.00% |
| DEUTSCHE BANK AG\ | 646 | $1,000 | 0.00% |